Co-Authors
This is a "connection" page, showing publications co-authored by Lukas Weseslindtner and Karin Stiasny.
Connection Strength
0.808
-
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. J Clin Microbiol. 2021 04 20; 59(5).
Score: 0.235
-
Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs. Infection. 2021 Feb; 49(1):171-175.
Score: 0.224
-
Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown. Sci Rep. 2021 05 12; 11(1):10158.
Score: 0.059
-
Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe. J Clin Med. 2021 Apr 28; 10(9).
Score: 0.059
-
A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence. Int J Environ Res Public Health. 2021 04 15; 18(8).
Score: 0.059
-
Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study. Pediatr Allergy Immunol. 2021 05; 32(4):762-770.
Score: 0.058
-
Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity. Front Med (Lausanne). 2020; 7:592629.
Score: 0.057
-
Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection. J Infect. 2021 02; 82(2):282-327.
Score: 0.056